Sound Investments. Solid Relationships.

Our Services

We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.

Investment Banking

Equity Research

Capital Markets

Merchant Capital

Wealth Management

Prime Brokerage

Recent
Transactions

Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021
Edible Garden® Ag, Inc., is a privately held, leader in locally grown organic produce and herbs backed by Zero-Waste Inspired® next generation farms. Edible Garden is leading the agriculture technology movement with its safety-in-farming protocols, sustainable packaging and patented self-watering in-store displays. The company currently operates state-of-the-art greenhouse and processing facilities in Belvidere, New Jersey, and in partnership with growers throughout the U.S. (PRNewsfoto/Edible Garden)
$14.7 Million
Initial Public Offering
// Lead Book-Running Manager
May 2022
maxim-column-blue
climaterock
$75.0 Million
Initial Public Offering
// Sole Book-Running Manager
May 2022
maxim-column-blue
ASPAC II
$185.0 Million
Initial Public Offering
// Sole Book-Running Manager
May 2022
maxim-column-blue
Capture
$294.1 Million
Business Combination
// Sole Financial Advisor to VCV Digital Technology
May 2022
maxim-column-blue
Dermata Therapeutics, LLC (PRNewsFoto/Dermata Therapeutics, LLC)
$5.0 Million
PIPE
// Sole Placement Agent
April 2022
maxim-column-blue
aclario
$9.4 Million
Initial Public Offering
// Sole Book-Running Manager
April 2022
maxim-column-blue
clarus_logo_rgb-2x
$30.0 Million
Follow-On Offering
// Sole Book-Running Manager
April 2022
maxim-column-blue
scynexis-color
$45.0 Million
CMPO
// Co-Lead Manager
April 2022
maxim-column-blue
seastar
Business Combination
// Financial Advisor to SeaStar Medical
April 2022
maxim-column-blue
VerifyMe Logo
$5.0 Million
PIPE
// Sole Placement Agent
April 2022
maxim-column-blue
sonicfoundry
$4.3 Million
Follow-On Offering
// Sole Book-Running Manager
April 2022
maxim-column-blue

Merchant Capital

Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.

Scroll to Top